Why Us?
1
Taiwan’s Largest
Biomedical Technology Repository
Integrating the research capabilities and cross-disciplinary resources of ITRI’s Biomedical Technology and Device Research Laboratories, we provide professional technical support and the most comprehensive biomedical industry linkage in Taiwan.
2
Regulatory Guidance for Market Approval
Navigating complex and high-threshold market approval processes can be challenging. Our professional regulatory team supports startups and enterprises throughout the entire journey — from R&D compliance assessment to cost evaluation — offering comprehensive consultation and full life-cycle guidance.
3
Clinical Fast Track
Connecting clinical institutions across northern, central, and southern Taiwan, we provide an end-to-end acceleration pathway — from product definition and pre-clinical validation to clinical execution and market launch.
4
Venture Capital & Funding Support
Bridging startups with venture capital and diverse financial instruments, we help overcome funding barriers. Our services include innovative financing solutions such as intangible asset loans, empowering commercialization and business scaling.
✽ Our Services
Startup Profiling
Using our Six-Dimension Evaluation Framework, we rapidly assess a startup team’s current status and capability gaps, providing customized matchmaking and acceleration pathways to strengthen growth and development.
Capital Strength｜Venture Capital & Funding
Connecting venture capital, biomedical intangible asset financing, and programs such as TWTM, we assist in project planning and application to enhance funding success rates.
Global Reach｜Channels & Partnerships
Leveraging our cross-disciplinary integration platform and overseas office network, we help startups enter target markets efficiently and foster international collaborations.
Manufacturing Capability｜CDMO
Connecting contract development and manufacturing organizations (CDMOs) and strategic alliance partners to strengthen mass production feasibility and commercialization capacity.
Regulatory Capability｜Compliance & Market Approval
Our regulatory affairs team provides consultation and roadmap planning for certifications such as TFDA, FDA, and CE, accelerating product compliance and market entry.
Clinical Capability｜Clinical Trials
Connecting medical centers and clinical experts to provide clinical insights, trial design support, and validation environments — accelerating clinical implementation and market readiness.
Technical Capability｜Technology Enhancement
Accessing ITRI Biomedical Research Laboratories’ R&D resources, we provide technical consultation and joint development support to assist in technology validation and advancement.
After completing the Six-Dimension Evaluation, we provide a customized Resource Matching Plan and milestone tracking to ensure every step — from technology development to market entry — is faster and more secure.
◎ Integrating ITRI’s cross-disciplinary industrialization expertise, we provide services spanning innovation and R&D, intellectual property, regulatory affairs, international marketing, and venture capital — shortening the time to market for emerging biomedical technologies.
Park Overview
Location
The Hsinchu Biomedical Science Park is located in Zhubei City, Hsinchu County, within the Hsinchu High-Speed Rail Station Special District, designated as an industrial zone covering 38.1 hectares.
It is approximately 8 km southwest of Hsinchu City Center and 3 km northwest of Zhubei City Hall and the Hsinchu County Government.
County Highway No. 120 runs along the north side of the Park, serving as the main access route.
The Park is conveniently connected to transportation hubs — including TRA Liujia Station, the National Freeway No. 1 (Sun Yat-sen Freeway) and No. 3 (Formosa Freeway) — and can be reached within 10 minutes from the Zhulin Interchange on Freeway 3.
Park Positioning
- The Hsinchu Biomedical Science Park is one of the public infrastructure projects under the “i-Taiwan 12 Projects” Industrial Innovation Corridor Initiative.
In response to global trends such as energy conservation, carbon reduction, aging populations, and the rise of the creative economy, the government has promoted six emerging industries — with biotechnology as a strategic priority.
This Park plays a key role by strengthening industrial R&D capacity, establishing an integrated biotechnology incubation center, and attracting private investment.
Through the combined resources of its three major centers, it aims to attract internationally renowned biomedical companies and research institutes, leveraging the advantages of Hsinchu Science Park and Taiwan’s ICT industry to create a synergistic innovation cluster.
The Park serves as a national platform for validating innovative technologies, accelerating industrialization, and positioning Taiwan as a leader in biomedical development. - The Hsinchu Biomedical Science Park operates under the National Science and Technology Council (NSTC) as part of the national Science Park System. Its administration, infrastructure, and operations are governed by the Science Park Administration (SPA) in accordance with the Act for Establishment and Administration of Science Parks and related regulations.
Research and Development Facilities
As a knowledge-driven and innovation-oriented science park, the Hsinchu Biomedical Science Park supports the full spectrum of biomedical industrialization.
Beyond standard park functions, it provides specialized facilities and services including: "Clinical trial infrastructure and support" , " Research centers and seed-stage incubation programs" , "Innovation and research networks (facilities and talent)" , "Collaborative clinical research" , "Regulatory consultation and guidance" .
Through shared platforms, open resources, and strong research-industry collaboration, the Park effectively reduces R&D and commercialization costs while increasing the success rate of biomedical startups — ensuring a solid foundation for Taiwan’s biomedical industry ecosystem.
Integrated R&D Ecosystem
The Park has established three major centers in alignment with its mission and functional objectives. Through a collaborative operational model, these centers integrate upstream, midstream, and downstream resources to foster innovation, research, and incubation for the biomedical industry. At the same time, horizontal collaboration mechanisms are built to create a unified biomedical research platform — integrating human resources and financial capital to enhance overall synergy, strengthen Taiwan’s biomedical foundation, and ensure the industry’s sustainable formation and scaling.
The Hsinchu Biomedical Science Park Hospital serves as the driving force behind the Park’s biomedical research and development.
By connecting healthcare, research, industry, and daily life, the hospital plays a dual role as both the initiator and the final validator of biomedical innovation.
Starting from clinical needs, it stimulates new biomedical research and works closely with the Biomedical Technology and Product Development Center to translate basic research into industrial and commercial applications.
It also functions as a validation hub, providing clinical trial settings and verification mechanisms that increase product success rates and strengthen industrial competitiveness.